The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Kailash Shantilal Choudhari, Promoter and Director of Aksh Optifibre Ltd, sold 1,90,628 equity shares (0.12% of total share capital) in the open market on September 29 and September 30, 2025. His individual holding came down from 48,97,020 shares (3.01%) to 47,06,392 shares (2.89%). The disclosure was filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The promoter group, including PACs such as Rohan Rashi Family Trust, Mrs. Mona Choudhari, Mr. Rohan Choudhari, and Ms. Rashi Choudhari, collectively holds around 8.60% of the company.
This is a small promoter sell-off (only 0.12% of equity), so it is unlikely to materially affect stock price or investor sentiment. It may reflect routine personal portfolio rebalancing rather than a loss of confidence in the company.